Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation

BACKGROUND: Guselkumab is a drug used to treat moderate to severe plaque psoriasis. However, real-life clinical data on its off-label use are limited, especially regarding the optimal drug dosage regimen for different patient profiles. OBJECTIVE: The main objective of this real-world, single-centre,...

Descripción completa

Detalles Bibliográficos
Autores principales: Herranz-Pinto, Pedro, Alonso-Pacheco, Maria Luisa, Feltes-Ochoa, Rosa, Mayor-Ibarguren, Ander, Servera-Negre, Guillermo, Busto-Leis, Jose Manuel, Gonzalez-Fernández, Maria Angeles, Herrero-Ambrosio, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374766/
https://www.ncbi.nlm.nih.gov/pubmed/37402097
http://dx.doi.org/10.1007/s40261-023-01280-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374766/
https://www.ncbi.nlm.nih.gov/pubmed/37402097
http://dx.doi.org/10.1007/s40261-023-01280-9

Ejemplares similares